Armata Pharmaceuticals (ARMP) Q4 2024 Annual Earnings
ARMP·Reported March 20, 2025·Before market open
Armata Pharmaceuticals reported Q4 2024 revenue of $1.2M, missed analyst consensus of $1.6M by $325.0K. Diluted EPS came in at $-0.23, beat the $-0.35 consensus by $0.12.
Revenue
$1.2Mmissed by $325.0K
Consensus: $1.6MDiluted EPS
$-0.23beat by $0.12
Consensus: $-0.35
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Armata Pharmaceuticals's Q4 2024 earnings report.
Armata Pharmaceuticals (ARMP) reported Q4 2024 earnings on March 20, 2025 before market open.
Armata Pharmaceuticals reported revenue of $1.2M and diluted EPS of $-0.23 for Q4 2024.
Revenue missed the consensus estimate of $1.6M by $325.0K. EPS beat the consensus estimate of $-0.35 by $0.12.
You can read the 10-K periodic report (0001558370-25-003406) directly on SEC EDGAR. The filing index links above go to sec.gov.